Trials / Completed
CompletedNCT06092567
Post-operative Sensitivity in Composite Restorations
Post-operative Sensitivity in Composites Using Bulk-fill vs. Oblique Incremental Placement Technique: a Double-blind, Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Pakistan Institute of Medical Sciences · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Participants will be divided into groups. In group A, Composite restoration done using oblique incremental technique. In group B, Bulk-fill technique was used. VAS scoring to evaluate the primary outcome at one day, one week and two weeks.
Detailed description
After the approval from ethical research committee, a written informed consent taken. Participants were briefed about the intervention with its associated merits and demerits. The restorative procedures were accomplished under rubber dam isolation using adequate local anesthesia. The principles of minimally intervention and adhesive dentistry were employed. Participants were allocated into two groups. In group A, restorative interventive was performed using Oblique incremental placement while in group B, Bulk-fill technique was used. Post-operative sensitivity was recorded at one day, one week and two week follow up using a Visual analogue scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Group A ( Oblique Incremental Placement Technique) | In this interventional group, a Nanohybrid composite resin Nexcomp (Meta Biomed, Korea) was placed using an oblique incremental technique with increments not exceeding 2 mm in thickness. |
| PROCEDURE | Group B (Bulk-fill Placement technique) | In this group, a composite Beautifil-Bulk Restorative (SHOFU dental) was utilized for restorative purposes using a bulk-fill technique with a thickness of 4 mm |
Timeline
- Start date
- 2022-12-20
- Primary completion
- 2023-07-24
- Completion
- 2023-07-24
- First posted
- 2023-10-23
- Last updated
- 2023-10-23
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06092567. Inclusion in this directory is not an endorsement.